期刊
EXPERT REVIEW OF RESPIRATORY MEDICINE
卷 7, 期 1, 页码 33-42出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/ERS.12.81
关键词
asthma; biomarkers; chronic cough; chronic obstructive pulmonary disease; eosinophils; idiopathic pulmonary fibrosis
资金
- GSK
- AstraZeneca
- MedImmune
- Novartis
- Chiesi
- Roche
Chronic lung diseases are very common and form a major threat to large proportions of the population with increased morbidity and mortality. Asthma is one of the most common eosinophilic airway diseases. However, there is growing evidence that eosinophilic inflammation is also important in subgroups of patients with chronic obstructive pulmonary disease, chronic cough and idiopathic pulmonary fibrosis. Several studies have shown that sputum eosinophilia is associated with a favorable response to treatment of corticosteroids in both asthma and chronic obstructive pulmonary disease, and tailored strategies aimed to normalize sputum eosinophils have resulted in a significant reduction in exacerbation rates. In this article, the authors review the role of eosinophilic inflammation in the diagnosis and management of chronic respiratory diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据